Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TGFB1 Antikörper

TGFB1 Reaktivität: Human, Maus, Ratte WB Wirt: Kaninchen Monoclonal R08-8B7 unconjugated
Produktnummer ABIN7384326
  • Target Alle TGFB1 Antikörper anzeigen
    TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))
    Reaktivität
    • 163
    • 102
    • 49
    • 23
    • 20
    • 15
    • 12
    • 11
    • 8
    • 7
    • 5
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    Human, Maus, Ratte
    Wirt
    • 190
    • 41
    • 3
    • 2
    • 1
    • 1
    Kaninchen
    Klonalität
    • 194
    • 43
    Monoklonal
    Konjugat
    • 93
    • 36
    • 32
    • 13
    • 8
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 4
    • 4
    • 4
    • 4
    • 4
    • 1
    Dieser TGFB1 Antikörper ist unkonjugiert
    Applikation
    • 177
    • 91
    • 68
    • 53
    • 52
    • 42
    • 35
    • 34
    • 29
    • 19
    • 18
    • 11
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    Western Blotting (WB)
    Aufreinigung
    Affinity Purified
    Klon
    R08-8B7
    Isotyp
    IgG
    Top Product
    Discover our top product TGFB1 Primärantikörper
  • Applikationshinweise
    WB 1:500-1:1000
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    300 μg/mL
    Buffer
    50 mM Tris-Glycine( pH 7.4), 0.15M NaCl, 40 % Glycerol, 0.01 % Sodium azide and 0.05 % BSA
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20°C. Avoid freeze / thaw cycles.
  • Target
    TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))
    Andere Bezeichnung
    TGF beta 1 (TGFB1 Produkte)
    Synonyme
    CED antikoerper, DPD1 antikoerper, LAP antikoerper, TGFB antikoerper, TGFbeta antikoerper, TGF-beta antikoerper, TGF-BETA-1 antikoerper, TGF-beta5 antikoerper, ced antikoerper, dpd1 antikoerper, lap antikoerper, tgf-beta antikoerper, tgfb antikoerper, tgfb5 antikoerper, tgfbeta antikoerper, TGF-beta1 antikoerper, TGFbeta1 antikoerper, Tgfb antikoerper, Tgfb-1 antikoerper, ai39657 antikoerper, tgfb1 antikoerper, wu:fb13a07 antikoerper, xx:ai39657 antikoerper, TGFB1 antikoerper, csd antikoerper, cdb1 antikoerper, cdg2 antikoerper, csd1 antikoerper, csd2 antikoerper, csd3 antikoerper, ebmd antikoerper, lcd1 antikoerper, bigh3 antikoerper, cdgg1 antikoerper, betaig-h3 antikoerper, TGFB4 antikoerper, transforming growth factor beta 1 antikoerper, transforming growth factor beta-1 antikoerper, transforming growth factor beta 1 L homeolog antikoerper, transforming growth factor, beta 1 antikoerper, transforming growth factor, beta 1a antikoerper, transforming growth factor beta induced L homeolog antikoerper, TGFB1 antikoerper, Tgfb1 antikoerper, tgfb1.L antikoerper, tgfb1a antikoerper, tgfbi.L antikoerper
    Hintergrund
    TGF beta 1,TGFB,CED,LAP,TGFB, also named as LAP and TGFB1, is a multifunctional peptide that controls proliferation, differentiation, and other functions in many cell types. TGFB acts synergistically with TGFA in inducing transformation. It also acts as a negative autocrine growth factor. Dysregulation of TGFB activation and signaling may result in apoptosis. Many cells synthesize TGFB and almost all of them have specific receptors for it. TGFB positively and negatively regulates many other growth factors. It plays an important role in bone remodeling as it is a potent stimulator of osteoblastic bone formation, causing chemotaxis, proliferation and differentiation in committed osteoblasts. It is highly expressed in bone. Mutation of TGFB are the cause of Camurati-Engelmann disease (CED) which known as progressive diaphyseal dysplasia 1 (DPD1).
    Molekulargewicht

    Observed_MW: 44kDa

    Calculated_MW: 44kDa

    Gen-ID
    7040
    UniProt
    P04202
    Pathways
    EGFR Signaling Pathway, Dopaminergic Neurogenesis, Cellular Response to Molecule of Bacterial Origin, Glycosaminoglycan Metabolic Process, Regulation of Leukocyte Mediated Immunity, Regulation of Muscle Cell Differentiation, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Production of Molecular Mediator of Immune Response, Ribonucleoside Biosynthetic Process, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus, Autophagie, Cancer Immune Checkpoints
Sie sind hier: